282 results
S-8
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (the “SIP”), the Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan (the “ESPP … ”), the Oruka Therapeutics, Inc. Amended and Restated 2024 Equity Incentive Plan (the “EIP”), and the Assumed Warrants (as defined below) to prevent dilution
S-8
EX-99.2
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
Exhibit 99.2 Director FORM ORUKA THERAPEUTICS, INC. 2024 stock INCENTIVE PLAN GRANT NOTICE FOR Nonqualified STOCK OPTIONS FOR GOOD AND VALUABLE … the terms and subject to the conditions set forth in this Grant Notice, the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (as amended from time
S-8
EX-5.1
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
(the “Common Stock”), issuable to eligible individuals under the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (the “SIP”), (ii) 463,489 shares of Common … the Oruka Therapeutics, Inc. Amended and Restated 2024 Equity Incentive Plan (together with the SIP and ESPP, the “Incentive Plans”) pursuant
S-8
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
Stock Incentive Plan Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan Oruka Therapeutics, Inc. Amended and Restated 2024 Equity Incentive … Incentive Plan (the “SIP”), (ii) 463,489 shares of Common Stock issuable under the Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan, (iii
S-8
EX-99.3
ORKA
Oruka Therapeutics Inc.
14 Nov 24
Registration of securities for employees
5:20pm
Exhibit 99.3 EMPLOYEE FORM ORUKA THERAPEUTICS, INC. 2024 stock INCENTIVE PLAN GRANT NOTICE FOR STOCK OPTIONS FOR GOOD AND VALUABLE CONSIDERATION … to the conditions set forth in this Grant Notice, the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (as amended from time to time, the “Plan
8-K
EX-99.1
qdyw3315jfo1bojj12
14 Nov 24
Report of Independent Registered Public Accounting Firm
4:56pm
8-K
EX-10.2
y8af3uk tazia5
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
jzywdvm
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
nm7czumqf ecry9gu
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
8-K
EX-99.3
bed3 dia3d
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.16
i8b9ajt
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.13
8119sj9dh3v0z8q0x7
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.11
syd2p7hbtwix85 7oe
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.4
0oxn1psgvfuj
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
ye9y5r709y
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.2
o2wwfw
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.10
sod19kyz
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm